Poland· PL-100470025
Lunsumio
A medicinal product containing mosunetuzumabum, registered in Poland by Roche Registration GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Mosunetuzumabum
- Manufacturer
- Roche Registration GmbH
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin07613326061001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mosunetuzumabum in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLunsumioOrifarm Oy
- BelgiumLunsumio 1 mgRoche Registration
- CzechiaLUNSUMIORoche Registration GmbH, Grenzach-Wyhlen
- IrelandLunsumio 1 mg concentrate for solution for infusionRoche Registration GmbH
- IcelandLunsumioRoche Registration GmbH*
- SwedenLunsumio 1 mg Koncentrat till infusionsvätska, lösningRoche Registration GmbH
- United StatesLunsumioGenentech, Inc.
- SpainLUNSUMIO 1 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONRoche Registration Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lunsumio
- Liechtenstein · Lunsumio
- Norway · Lunsumio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/215848c2-988b-48e2-bac2-c971fd6f0153 GET /v1/drugs/215848c2-988b-48e2-bac2-c971fd6f0153?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "1 mg",
"packaging": "07613326061001 ¦ Rpz ¦ EU/1/22/1649/001 ¦ 145411\n1 fiol. 1 ml",
"substance": "Mosunetuzumabum 1 mg",
"common_name": "Mosunetuzumabum",
"pl_product_id": "100470025",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about mosunetuzumabum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.